Terry-Ann Burrell
Director of Finance/CFO presso BEAM THERAPEUTICS INC.
Patrimonio netto: 3 M $ in data 31/03/2024
Profilo
Attualmente, Terry-Ann Burrell ricopre la posizione di direttore finanziario e tesoriere di Beam Therapeutics, Inc. La signora Burrell è anche nel consiglio di amministrazione di Recursion Pharmaceuticals, Inc. Nella sua carriera passata ha occupato la posizione di amministratore delegato presso JPMorgan Securities LLC. La signora Burrell ha conseguito una laurea presso l'Università di Harvard e un MBA presso la Leonard N Stern School of Business.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
BEAM THERAPEUTICS, INC.
0.09% | 01/04/2024 | 70 137 ( 0.09% ) | 2 M $ | 31/03/2024 |
| 01/04/2024 | 56 314 ( 0.03% ) | 561 451 $ | 31/03/2024 |
Posizioni attive di Terry-Ann Burrell
| Società | Posizione | Inizio |
|---|---|---|
| BEAM THERAPEUTICS INC. | Director of Finance/CFO | 01/08/2019 |
| RECURSION PHARMACEUTICALS, INC. | Director/Board Member | 01/04/2020 |
Rapport Therapeutics, Inc.
 Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. is an American clinical-stage biotechnology company that focuses on discovering and developing medicines for neurological disorders. The CEO of the company is Abraham N. Ceesay. | Director/Board Member | 16/01/2024 |
Precedenti posizioni note di Terry-Ann Burrell
| Società | Posizione | Fine |
|---|---|---|
JPMorgan Securities LLC
 JPMorgan Securities LLC Investment Banks/BrokersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Corporate Officer/Principal | 01/08/2019 |
Formazione di Terry-Ann Burrell
| Harvard University | Undergraduate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| RECURSION PHARMACEUTICALS, INC. | Health Technology |
| BEAM THERAPEUTICS INC. | Health Technology |
| Aziende private | 2 |
|---|---|
JPMorgan Securities LLC
JPMorgan Securities LLC Investment Banks/BrokersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Finance |
Rapport Therapeutics, Inc.
Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. is an American clinical-stage biotechnology company that focuses on discovering and developing medicines for neurological disorders. The CEO of the company is Abraham N. Ceesay. | Health Technology |
- Borsa valori
- Insiders
- Terry-Ann Burrell
